Changes in Ciprofol Dosage in Insomnia Patients Undergoing Digestive Endoscopy
Launched by BEIJING TIANTAN HOSPITAL · Mar 20, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The investigators aim to investigate whether ciprofol dosage requirement is increased in patients with insomnia undergoing digestive endoscopy compared with normal sleep patterns.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients with insomnia:
- • 1. Age of 18 - 64 years;
- • 2. ASA physical status of I - II;
- • 3. BMI of 15 - 30;
- • 4. Scheduled for digestive endoscopy under intravenous anesthesia;
- • 5. Positive screening results according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for insomnia disorder;
- • 6. 8-item Sleep Condition Indicator (SCI; score 0-4; range 0-32, higher score means better sleep) scored 16 or less;
- * Patients with normal sleep:
- • 1. Age of 18 - 64 years;
- • 2. ASA physical status of I - II;
- • 3. BMI of 15 - 30;
- • 4. Scheduled for digestive endoscopy under intravenous anesthesia;
- • 5. No history or evidence of insomnia.
- Exclusion Criteria:
- • 1. Associated with any neurological disease;
- • 2. Daily alcohol consumption;
- • 3. Any contraindication to intravenous anesthetic drug, such as hypotension or shock;
- • 4. History of allergy to any drug used in the study;
- • 5. Pregnancy or breastfeeding;
- • 6. Patients with sleep apnea syndrome;
- • 7. acute upper respiratory infection;
- • 8. Patients with psychological diseases who report suicidal thoughts;
- • 9. Patients who need to work or take care of children/elderly people frequently at night.
About Beijing Tiantan Hospital
Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported